Moolec Science S.A.
MLEC · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 69.7% | 2.2% | -27.8% | – |
| Cost of Goods Sold | $3 | $2 | $2 | $2 |
| Gross Profit | -$1 | $0 | -$0 | $0 |
| % Margin | -25.5% | 0.9% | -4.7% | 4.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $2 | $2 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $1 | $2 | $3 | $2 |
| Operating Income | -$2 | -$2 | -$3 | -$2 |
| % Margin | -77.9% | -135% | -193% | -96.8% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | $1 |
| Pre-Tax Income | -$2 | -$2 | -$3 | -$1 |
| Tax Expense | $0 | -$0 | -$1 | $0 |
| Net Income | -$2 | -$2 | -$3 | -$1 |
| % Margin | -91.8% | -123% | -166.5% | -66.5% |
| EPS | -0.06 | -0.05 | -0.07 | -0.04 |
| % Growth | -20% | 28.6% | -75% | – |
| EPS Diluted | -0.06 | -0.05 | -0.07 | -0.04 |
| Weighted Avg Shares Out | 39 | 39 | 36 | 38 |
| Weighted Avg Shares Out Dil | 39 | 39 | 36 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$2 | -$1 |
| % Margin | -43.6% | -68.6% | -155.3% | -29.7% |